|
|
Medical Diagnosis 2024
多囊卵巢综合征与代谢综合征各组分关系的研究进展
|
Abstract:
多囊卵巢综合征(Polycystic ovary syndrome, PCOS)是育龄期女性常见的妇科生殖内分泌疾病，严重影响女性的生殖健康。近年来，PCOS的发病率逐年上升，这一趋势引起了国内外学者的广泛关注。PCOS患者常与肥胖、胰岛素抵抗、高脂血症等代谢综合征(Metabolic syndrome, MetS)各组分密切相关，PCOS合并MetS一种或多种组分常常加重病情的发展。本文就PCOS与MetS各组分的相关调查研究进行综述。
Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder in women of childbearing age, significantly affecting women’s reproductive health. In recent years, the incidence of PCOS has been increasing annually, a trend that has attracted widespread attention from domestic and foreign scholars. PCOS patients are often closely associated with components of metabolic syndrome (MetS) such as obesity, insulin resistance, and dyslipidemia. The presence of one or more components of MetS in PCOS patients often exacerbates the progression of the disease. This article provides a review of the research on the relationship between PCOS and the various components of MetS.
| [1] | Joham, A.E., Norman, R.J., Stener-Victorin, E., Legro, R.S., Franks, S., Moran, L.J., Boyle, J. and Teede, H.J. (2022) Polycystic Ovary Syndrome. The Lancet Diabetes & Endocrinology, 10, 668-680. https://doi.org/10.1016/S2213-8587(22)00163-2 |
| [2] | Dapas, M. and Dunaif, A. (2022) Deconstructing a Syndrome: Genomic Insights into PCOS Causal Mechanisms and Classification. Endocrine Reviews, 43, 927-965. https://doi.org/10.1210/endrev/bnac001 |
| [3] | 尹婧雯, 杨纨 ,于多, 等. 多囊卵巢综合征评估和管理国际循证指南推荐建议(2023年版). 中华生殖与避孕杂志, 2023, 43(11): 1099-1113. https://doi.org/10.3760/cma.j.cn101441-20231010-00153 |
| [4] | Saklayen, M.G. (2018) The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, 20, Article No. 12. https://doi.org/10.1007/s11906-018-0812-z |
| [5] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华内分泌代谢杂志, 2021, 37(4): 311. https://doi.org/10.3760/cma.j.cn311282-20210304-00142 |
| [6] | Godman, B., Basu, D. and Pillay, Y. (2020) Review of Ongoing Activities and Challenges to Improve the Care of Patients with Type 2 Diabetes across Africa and the Implications for the Future. Frontiers in Pharmacology, 11, Article No. 108. https://doi.org/10.3389/fphar.2020.00108 |
| [7] | De Brandt, E. and Hillary, T. (2022) Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management. Psoriasis (Auckl), 12, 113-126. https://doi.org/10.2147/PTT.S293107 |
| [8] | Souza Cruz, E.M., Bitencourt De Morais, J.M., Dalto Da Rosa, C.V., Da Silva Sim？es, M., Comar, J.F., De Almeida Chuffa, L.G. and Seiva, F.R.F. (2020) Long-Term Sucrose Solution Consumption Causes Metabolic Alterations and Affects Hepatic Oxidative Stress in Wistar Rats. Biology Open, 9, Bio047282. https://doi.org/10.1242/bio.047282 |
| [9] | Liu, J., Bai, L., Wang, W., Song, Y., Zhao, W., Li, Q. and Wu, Q. (2022) LC-MS-Based Lipidomic Analysis of Serum Samples from Patients with Type 2 Diabetes Mellitus (T2DM). Disease Markers, 2022, Article ID: 5559470. https://doi.org/10.1155/2022/5559470 |
| [10] | Takeyama, N., Moriyama, M., Kazawa, K., Steenkamp, M. and Rahman, M.M. (2020) A Health Guidance App to Improve Motivation, Adherence to Lifestyle Changes and Indicators of Metabolic Disturbances among Japanese Civil Servants. International Journal of Environmental Research and Public Health, 17, Article No. 8147. https://doi.org/10.3390/ijerph17218147 |
| [11] | Chen, Y., Guo, J., Zhang, Q. and Zhang, C. (2022) Insulin Resistance Is a Risk Factor for Early Miscarriage and Macrosomia in Patients with Polycystic Ovary Syndrome from the First Embryo Transfer Cycle: A Retrospective Cohort Study. Frontiers in Endocrinology (Lausanne), 13, Article ID: 853473. https://doi.org/10.3389/fendo.2022.853473 |
| [12] | Lemieux, I. and Despres, J.P. (2020) Metabolic Syndrome: Past, Present and Future. Nutrients, 12, Article No. 3501. https://doi.org/10.3390/nu12113501 |
| [13] | Zaeemzadeh, N., Sadatmahalleh, S.J., Ziaei, S., Kazemnejad, A., Mottaghi, A., Mohamadzadeh, N. and Movahedinejad, M. (2020) Prevalence of Metabolic Syndrome in Four Phenotypes of PCOS and Its Relationship with Androgenic Components among Iranian Women: A Cross-Sectional Study. International Journal of Reproductive BioMedicine, 18, 253-264. https://doi.org/10.18502/ijrm.v13i4.6888 |
| [14] | Dietz De Loos, A., Jiskoot, G., Beerthuizen, A., Busschbach, J. and Laven, J. (2021) Metabolic Health during a Randomized Controlled Lifestyle Intervention in Women with PCOS. European Journal of Endocrinology, 186, 53-64. https://doi.org/10.1530/EJE-21-0669 |
| [15] | Li, T., Zhang, Y., Song, J., Chen, L., Du, M. and Mao, X. (2022) Yogurt Enriched with Inulin Ameliorated Reproductive Functions and Regulated Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice. Nutrients, 14, Article No. 279. https://doi.org/10.3390/nu14020279 |
| [16] | Javed, Z., Papageorgiou, M., Deshmukh, H., Kilpatrick, E.S., Mann, V., Corless, L., Abouda, G., Rigby, A.S., Atkin, S.L. and Sathyapalan, T. (2019) A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Nutrients, 11, Article No. 188. https://doi.org/10.3390/nu11010188 |
| [17] | Kumarendran, B., O’Reilly, M.W., Manolopoulos, K.N., Toulis, K.A., Gokhale, K.M., Sitch, A.J., Wijeyaratne, C.N., Coomarasamy, A., Arlt, W. and Nirantharakumar, K. (2018) Polycystic Ovary Syndrome, Androgen Excess, and the Risk of Nonalcoholic Fatty Liver Disease in Women: A Longitudinal Study Based on a United Kingdom Primary Care Database. PLOS Medicine, 15, e1002542. https://doi.org/10.1371/journal.pmed.1002542 |
| [18] | Kulshreshtha, B., Sharma, N., Pant, S., Prasad, A., Chitkara, A., Pahuja, B. and Pahuja, I. (2019) Predictors of Metabolic Syndrome among Polycystic Ovary Syndrome Sisters. Journal of Human Reproductive Sciences, 12, 334-340. https://doi.org/10.4103/jhrs.JHRS_172_18 |
| [19] | Ali, A.T. and Guidozzi, F. (2020) Midlife Women’s Health Consequences Associated with Polycystic Ovary Syndrome. Climacteric, 23, 116-122. https://doi.org/10.1080/13697137.2019.1679111 |
| [20] | Hallajzadeh, J., Khoramdad, M., Karamzad, N., Almasi-Hashiani, A., Janati, A., Ayubi, E., Pakzad, R., Sullman, M.J.M. and Safiri, S. (2018) Metabolic Syndrome and Its Components among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Journal of Cardiovascular and Thoracic Research, 10, 56-69. https://doi.org/10.15171/jcvtr.2018.10 |
| [21] | Apridonidze, T., Essah, P.A., Iuorno, M.J. and Nestler, J.E. (2005) Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 90, 1929-1935. https://doi.org/10.1210/jc.2004-1045 |
| [22] | Marcondes, J.A., Hayashida, S.A., Barcellos, C.R., Rocha, M.P., Maciel, G.A. and Baracat, E.C. (2007) Metabolic Syndrome in Women with Polycystic Ovary Syndrome: Prevalence, Characteristics and Predictors. Arquivos Brasileiros de Endocrinologia e Metabologia, 51, 972-979. https://doi.org/10.1590/S0004-27302007000600012 |
| [23] | Madani, T., Hosseini, R., Ramezanali, F., Khalili, G., Jahangiri, N., Ahmadi, J., Rastegar, F. and Zolfaghari, Z. (2016) Metabolic Syndrome in Infertile Women with Polycystic Ovarian Syndrome. Archives of Endocrinology and Metabolism, 60, 199-204. https://doi.org/10.1590/2359-3997000000135 |
| [24] | Huang, R., Zheng, J., Li, S.X., Tao, T., Ma, J. and Liu, W. (2015) Characteristics and Contributions of Hyperandrogenism to Insulin Resistance and Other Metabolic Profiles in Polycystic Ovary Syndrome. Acta Obstetricia et Gynecologica Scandinavica, 94, 494-500. https://doi.org/10.1111/aogs.12612 |
| [25] | Sharma, S. and Majumdar, A. (2015) Prevalence of Metabolic Syndrome in Relation to Body Mass Index and Polycystic Ovarian Syndrome in Indian Women. Journal of Human Reproductive Sciences, 8, 202. https://doi.org/10.4103/0974-1208.170394 |
| [26] | Carmina, E., Napoli, N., Longo, R.A., Rini, G.B. and Lobo, R.A. (2006) Metabolic Syndrome in Polycystic Ovary Syndrome (PCOS): Lower Prevalence in Southern Italy than in the USA and the Influence of Criteria for the Diagnosis of PCOS. European Journal of Endocrinology, 154, 141-145. https://doi.org/10.1530/eje.1.02058 |
| [27] | Pu, D., Li, L., Yin, J., Liu, R., Yang, G., Liao, Y. and Wu, Q. (2019) Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women. Mediators of Inflammation, 2019, Article ID: 6321427. https://doi.org/10.1155/2019/6321427 |
| [28] | Yao, K., Bian, C. and Zhao, X. (2017) Association of Polycystic Ovary Syndrome with Metabolic Syndrome and Gestational Diabetes: Aggravated Complication of Pregnancy. Experimental and Therapeutic Medicine, 14, 1271-1276. https://doi.org/10.3892/etm.2017.4642 |
| [29] | Bjercke, S., Dale, P.O., Tanbo, T., Storeng, R., Ertzeid, G. and Abyholm, T. (2002) Impact of Insulin Resistance on Pregnancy Complications and Outcome in Women with Polycystic Ovary Syndrome. Gynecologic and Obstetric Investigation, 54, 94-98. https://doi.org/10.1159/000067719 |
| [30] | Weerakiet, S., Srisombut, C., Rojanasakul, A., Panburana, P., Thakkinstian, A. and Herabutya, Y. (2004) Prevalence of Gestational Diabetes Mellitus and Pregnancy Outcomes in Asian Women with Polycystic Ovary Syndrome. Gynecological Endocrinology, 19, 134-140. https://doi.org/10.1080/09513590400007242 |
| [31] | 多囊卵巢综合征诊治路径专家共识编写组. 多囊卵巢综合征诊治路径专家共识[J]. 中华生殖与避孕杂志, 2023, 43(4): 337-345. https://doi.org/10.3760/cma.j.cn101441-20220927-00417 |
| [32] | Garoufi, A., Pagoni, A., Papadaki, M., Marmarinos, A., Karapostolakis, G., Michala, L. and Soldatou, A. (2021) Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index. Children (Basel), 9, Article No. 4. https://doi.org/10.3390/children9010004 |
| [33] | Glueck, C.J. and Goldenberg, N. (2019) Characteristics of Obesity in Polycystic Ovary Syndrome: Etiology, Treatment, and Genetics. Metabolism, 92, 108-120. https://doi.org/10.1016/j.metabol.2018.11.002 |
| [34] | Jurczewska, J., Ostrowska, J., Che？chowska, M., Panczyk, M., Rudnicka, E., Kucharski, M., Smolarczyk, R. and Szostak-W？gierek, D. (2023) Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study. Nutrients, 15, Article No. 3652. https://doi.org/10.3390/nu15163652 |
| [35] | Anagnostis, P., Tarlatzis, B.C. and Kauffman, R.P. (2018) Polycystic Ovarian Syndrome (PCOS): Long-Term Metabolic Consequences. Metabolism, 86, 33-43. https://doi.org/10.1016/j.metabol.2017.09.016 |
| [36] | Ahmed, B., Sultana, R. and Greene, M.W. (2021) Adipose Tissue and Insulin Resistance in Obese. Biomedicine & Pharmacotherapy, 137, Article ID: 111315. https://doi.org/10.1016/j.biopha.2021.111315 |
| [37] | Zhu, S., Li, Z., Hu, C., Sun, F., Wang, C., Yuan, H. and Li, Y. (2021) Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology (Lausanne), 12, Article ID: 697223. https://doi.org/10.3389/fendo.2021.697223 |
| [38] | Lim, S.S., Hutchison, S.K., Van Ryswyk, E., Norman, R.J., Teede, H.J. and Moran, L.J. (2019) Lifestyle Changes in Women with Polycystic Ovary Syndrome. Cochrane Database of Systematic Reviews, 3, CD007506. https://doi.org/10.1002/14651858.CD007506.pub4 |
| [39] | Girard, D. and Vandiedonck, C. (2022) How Dysregulation of the Immune System Promotes Diabetes Mellitus and Cardiovascular Risk Complications. Frontiers in Cardiovascular Medicine, 9, Article ID: 991716. https://doi.org/10.3389/fcvm.2022.991716 |
| [40] | Huang, J., Ni, R., Chen, X., Huang, L., Mo, Y. and Yang, D. (2010) Metabolic Abnormalities in Adolescents with Polycystic Ovary Syndrome in South China. Reproductive Biology and Endocrinology, 8, Article No. 142. https://doi.org/10.1186/1477-7827-8-142 |
| [41] | Tomlinson, J., Millward, A., Stenhouse, E. and Pinkney, J. (2010) Type 2 Diabetes and Cardiovascular Disease in Polycystic Ovary Syndrome: What Are the Risks and Can They Be Reduced? Diabetic Medicine, 27, 498-515. https://doi.org/10.1111/j.1464-5491.2010.02994.x |
| [42] | Engin, A. (2017) The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. Advances in Experimental Medicine and Biology, 960, 221-245. https://doi.org/10.1007/978-3-319-48382-5_9 |
| [43] | Barber, T.M., Kyrou, I., Randeva, H.S. and Weickert, M.O. (2021) Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction. International Journal of Molecular Sciences, 22, Article No. 546. https://doi.org/10.3390/ijms22020546 |
| [44] | 刘媛媛, 唐蓉. 多囊卵巢综合征患者糖代谢异常相关基因研究进展[J]. 现代妇产科进展, 2021, 30(9): 716-718. https://doi.org/10.13283/j.cnki.xdfckjz.2021.09.009 |
| [45] | Zhu, T., Cui, J. and Goodarzi, M.O. (2021) Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke. Diabetes, 70, 627-637. https://doi.org/10.2337/db20-0800 |
| [46] | 黄中华, 王忠康, 周兴, 等. 代谢综合征与非肌层浸润性膀胱癌关系的研究进展[J]. 国际泌尿系统杂志, 2019, 39(2): 323-323. https://doi.org/10.3760/cma.j.issn.1673-4416.2019.02.040 |
| [47] | Roa Barrios, M., Arata-Bellabarba, G., Valeri, L. and Velázquez-Maldonado, E. (2009) Relationship between the Triglyceride/High-Density Lipoprotein-Cholesterol Ratio, Insulin Resistance Index and Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome. Endocrinología y Nutrición, 56, 59-65. https://doi.org/10.1016/S1575-0922(09)70553-4 |
| [48] | Lankarani, M., Valizadeh, N., Heshmat, R., Peimani, M. and Sohrabvand, F. (2009) Evaluation of Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome. Gynecological Endocrinology, 25, 504-507. https://doi.org/10.1080/09513590902972083 |
| [49] | Guo, F., Gong, Z., Fernando, T., Zhang, L., Zhu, X. and Shi, Y. (2022) The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population. Frontiers in Endocrinology (Lausanne), 13, Article ID: 892125. https://doi.org/10.3389/fendo.2022.892125 |
| [50] | Maffazioli, G., Lopes, C.P., Heinrich-Oliveira, V., et al. (2020) Prevalence of Metabolic Disturbances among Women with Polycystic Ovary Syndrome in Different Regions of Brazil. International Journal of Gynecology & Obstetrics, 151, 383-391. https://doi.org/10.1002/ijgo.13374 |
| [51] | Osibogun, O., Ogunmoroti, O. and Michos, E.D. (2020) Polycystic Ovary Syndrome and Cardiometabolic Risk: Opportunities for Cardiovascular Disease Prevention. Trends in Cardiovascular Medicine, 30, 399-404. https://doi.org/10.1016/j.tcm.2019.08.010 |
| [52] | Santoro, N., Schauer, I.E., Kuhn, K., Fought, A.J., Babcock-Gilbert, S. and Bradford, A.P. (2021) Gonadotropin Response to Insulin and Lipid Infusion Reproduces the Reprometabolic Syndrome of Obesity in Eumenorrheic Lean Women: A Randomized Crossover Trial. Fertility and Sterility, 116, 566-574. https://doi.org/10.1016/j.fertnstert.2021.03.005 |
| [53] | Bates, G.W. and Legro, R.S. (2013) Long Term Management of Polycystic Ovarian Syndrome (PCOS). Molecular and Cellular Endocrinology, 373, 91-97. https://doi.org/10.1016/j.mce.2012.10.029 |
| [54] | Cassidy-Vu, L., Joe, E. and Kirk, J.K. (2016) Role of Statin Drugs for Polycystic Ovary Syndrome. Journal of Family and Reproductive Health, 10, 165-175. |
| [55] | Macut, D., Mladenovi？, V., Bjeki？-Macut, J., Livadas, S., Stanojlovi？, O., Hrn？i？, D., Ra？i？-Markovi？, A., Milutinovi？, D.V. and Andri？, Z. (2020) Hypertension in Polycystic Ovary Syndrome: Novel Insights. Current Hypertension Reviews, 16, 55-60. https://doi.org/10.2174/1573402115666190531071422 |
| [56] | Joham, A.E., Kakoly, N.S., Teede, H.J. and Earnest, A. (2021) Incidence and Predictors of Hypertension in a Cohort of Australian Women with and without Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 106, 1585-1593. https://doi.org/10.1210/clinem/dgab134 |
| [57] | Dokras, A. (2013) Cardiovascular Disease Risk in Women with PCOS. Steroids, 78, 773-776. https://doi.org/10.1016/j.steroids.2013.04.009 |
| [58] | Mills, G., Badeghiesh, A., Suarthana, E., Baghlaf, H. and Dahan, M.H. (2020) Polycystic Ovary Syndrome as an Independent Risk Factor for Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Population-Based Study on 9.1 Million Pregnancies. Human Reproduction, 35, 1666-1674. https://doi.org/10.1093/humrep/deaa099 |
| [59] | Adoga, J.O., Channa, M.L. and Nadar, A. (2021) Kolaviron Attenuates Cardiovascular Injury in Fructose-Streptozotocin Induced Type-2 Diabetic Male Rats by Reducing Oxidative Stress, Inflammation, and Improving Cardiovascular Risk Markers. Biomedicine & Pharmacotherapy, 144, Article ID: 112323. https://doi.org/10.1016/j.biopha.2021.112323 |
| [60] | Welt, C.K. and Carmina, E. (2013) Clinical Review: Lifecycle of Polycystic Ovary Syndrome (PCOS): From in Utero to Menopause. The Journal of Clinical Endocrinology & Metabolism, 98, 4629-4638. https://doi.org/10.1210/jc.2013-2375 |
| [61] | Glintborg, D. (2016) Endocrine and Metabolic Characteristics in Polycystic Ovary Syndrome. Danish Medical Journal, 63, B5232. |
| [62] | Bird, S.T., Hartzema, A.G., Brophy, J.M., Etminan, M. and Delaney, J.A. (2013) Risk of Venous Thromboembolism in Women with Polycystic Ovary Syndrome: A Population-Based Matched Cohort Analysis. CMAJ, 185, E115-E120. https://doi.org/10.1503/cmaj.120677 |
